D-0444-2026 Class II Ongoing
FDA drug recall D-0444-2026 was initiated by Viatris, Inc. on Mar 17, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 15, 2026
- Initiation Date
- Mar 17, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product Description
Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91
Reason for Recall
Failed Dissolution Specifications
Distribution Pattern
US Nationwide.
Code Information
Lot# 8177156, Exp Date: 02/28/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0444-2026
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026